| COMPOSITION: | Each hard gelatin capsule contains Rabeprazole 20 mg (EC) and Itopride (SR) 150 mg |
| FORMULATION: | CAPSULES |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Renvorab-IT Capsules contains Rabeprazole, a PPI that inhibits acid & Itopride, a Prokinetic drug that increases the movement in GI tract. It is indicated in the treatment of gastroesophageal reflux disease (GERD) in Patients who do not respond to monotherapy with PPI?s. It is also indicated in Zollinger-Ellison syndrome, gastric and duodenal ulcers. |
| SIDE EFFECTS: | Common side effects are headache, nausea, vomiting, gas, joint pain, diarrhea, dizziness |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
